Invicta Diagnostic IPO
ClosedAlready have an account? Apply now
Invicta Diagnostic IPO details
Schedule of Invicta Diagnostic
| Issue open date | 01 Dec 2025 |
| Issue close date | 03 Dec 2025 |
| UPI mandate deadline | 03 Dec 2025 (5 PM) |
| Allotment finalization | 04 Dec 2025 |
| Refund initiation | 05 Dec 2025 |
| Share credit | 05 Dec 2025 |
| Listing date | 08 Dec 2025 |
| Mandate end date | 18 Dec 2025 |
| Lock-in end date for anchor investors (50%) | 03 Jan 2026 |
| Lock-in end date for anchor investors (remaining) | 04 Mar 2026 |
Note: The schedule is tentative. The anchor lock-in period ends 30 days after the actual allotment date for 50% of the shares and 90 days after for the remaining portion. The allotment status can be checked on the registrar's website and the exchange website.
About Invicta Diagnostic
Invicta Diagnostic Limited is an integrated diagnostic services provider based in the Mumbai Metropolitan Region. The company was founded in 2021 and is promoted by Dr Ketan Jain and Dr Sanket Jain, experienced radiologists with deep industry expertise. Operating under the brand PC Diagnostics, the company offers comprehensive radiology and pathology services.
Its network includes a flagship centre in Thane, multiple hub centres, spoke centres, and a centralised laboratory, delivering advanced tests such as MRI, CT, PET CT, X-ray, sonography, and a full suite of pathology services. Invicta follows a hub-and-spoke business model that enhances efficiency and ensures consistent, high-quality results.
With a strong medical team, modern equipment, and a technology-driven workflow, the company focuses on accuracy, affordability, and customer convenience. Its growing footprint and rising revenues reflect its position as a reliable, service-oriented diagnostics brand.
Financials of Invicta Diagnostic
Issue size
| Funds Raised in the IPO | Amount |
| Total issue size | 28.12 |
| Fresh Issue – Proceeds go to the company | 28.12 |
Utilisation of proceeds
| Purpose | INR crores (%) |
| Medical equipment purchase for five new Maharashtra centres | 21.11 (75.08%) |
| General corporate purpose | 7.01 (24.92%) |
Strengths
-
Integrated diagnostic service provider with both radiology and pathology offerings.
-
Operates a scalable hub-and-spoke model enabling efficiency and wider reach.
-
Experienced promoters with strong medical and industry backgrounds.
-
Growing network of diagnostic centres in high-demand urban regions.
- Strong focus on technology, quality systems, and modern diagnostic equipment.
Risks
-
Business heavily depends on promoters’ expertise and continued involvement.
-
High capital expenditure and equipment maintenance may impact profitability.
-
Industry faces intense competition from established diagnostic chains.
-
Regulatory changes in healthcare and diagnostics may affect operations.
- Revenue concentration in limited geographical regions increases business risk.
Allotment Status for Invicta Diagnostic
To check your IPO allotment status:
- Visit the Bigshare Services IPO Application Status page.
- Select the company name from the dropdown menu.
- Select and enter one of the following: PAN, Application Number, DP/Client ID, or Account Number/IFSC.
- Click Submit to view your allotment status.
Subscription Figures for Invicta Diagnostic
As per media reports (Link), the Grey Market Premium (GMP) of Invicta Diagnostic is reported at ₹0 over the IPO price. This metric is not reliable, and to track IPO interest, it is better to check subscription numbers published by exchanges, which are considered more reliable indicators.
Subscription numbers as of 5:00 PM on December 03, 2025:
| Category | Reserved (lakhs) | Applied (lakhs) | Subscription (X times) |
|---|---|---|---|
| Institutional | 5.34 | 18.75 | 3.51x |
| NII | 5.42 | 37.74 | 6.96x |
| Retail | 12.67 | 43.42 | 3.43x |
| Total | 23.44 | 99.92 | 4.26x |